Stocks 27 May 2026 - 2 June 2026

Liquidia Sinks 5% After Recent Rally
····

Liquidia Sinks 5% After Recent Rally

Liquidia shares held steady in early Tuesday trading after dropping 5% Monday to $58.75. The company reported Q1 YUTREPIA net sales of $129.9 million and over 4,500 prescriptions since its June 2025 launch. CEO Roger Jeffs and CFO Michael Kaseta will give a business update at the Jefferies Global Healthcare Conference on Wednesday. Legal risks remain as United Therapeutics seeks to block YUTREPIA sales.
June 2, 2026
GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce
····

GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce

GIBO Holdings shares rose 3.1% to $1.34 in thin premarket trading Tuesday, recovering some of Monday’s losses. The company reported no revenue for 2025 and a $231.9 million net loss, with its auditor warning of “substantial doubt” about its ability to continue. GIBO had $402,736 in cash at year-end and agreed to a $5 million credit facility. The stock remains volatile, with a 52-week range of $1.16 to $538.
June 2, 2026
Capricor Shares Fall, FDA Call in August Looms
····

Capricor Shares Fall, FDA Call in August Looms

Capricor Therapeutics shares fell 4.8% to $28.53 on Monday, bucking gains in major U.S. indexes. The company’s market value stands near $1.64 billion as investors await the FDA’s Aug. 22 decision on its experimental Duchenne muscular dystrophy therapy, deramiocel. Biotech stocks broadly declined, with the Nasdaq Biotechnology Index down 1.9%. Trading resumes Tuesday morning in New York.
June 2, 2026
Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders
····

Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders

Pulmatrix shares fell 1.44% to $1.37 in thin early Nasdaq trading Monday, with no new company news since its May 15 quarterly report and Eos merger update. Holders are expected to own about 6% of the combined company if the Eos deal closes. Pulmatrix reported $3.3 million in cash at March 31 and warned of “substantial doubt” about its ability to continue without the merger.
June 1, 2026
Rezolute Shares Edge Higher Ahead of Key FDA Week
····

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute shares rose 4 cents to $3.30 in premarket Nasdaq trading Monday, ahead of the company’s appearance at the Jefferies Global Healthcare Conference. The FDA has not approved Rezolute’s main drug, ersodetug, after its Phase 3 trial in congenital hyperinsulinism missed its primary endpoint. Rezolute reported $120.3 million in cash at March’s end, down from $167.9 million in June 2025.
June 1, 2026
Gentherm Faces Pivotal Week After Shares Rebound 6%
····

Gentherm Faces Pivotal Week After Shares Rebound 6%

Gentherm shares closed Friday at $34.69, up nearly 6% in five days but down 4.62% for the year. The company holds investor meetings this week as it pursues a $1 billion Reverse Morris Trust merger with Modine Performance Technologies, giving Gentherm holders about 60% of the new group. Q1 revenue rose 11.3% to $393.7 million. Management reaffirmed 2026 revenue guidance at $1.5–$1.6 billion.
June 1, 2026
Baldwin Insurance Shares Dip as Wall Street Hits Record Highs
······

Baldwin Insurance Shares Dip as Wall Street Hits Record Highs

Baldwin Insurance Group shares fell 2.2% to $19.42 Friday, underperforming as the S&P 500 and Nasdaq closed at record highs. The stock lost 1.2% for the holiday-shortened week. Baldwin reported Q1 revenue up 29% to $532.2 million, but posted a net loss of $1.9 million. CEO Trevor Baldwin and CFO Brad Hale will speak at the William Blair Growth Stock Conference on June 3.
June 1, 2026
EGH Stock Drifts Near $10.35 as Hecate Deal Deadline Looms
·····

EGH Stock Drifts Near $10.35 as Hecate Deal Deadline Looms

EGH Acquisition Corp. closed Friday at $10.35, nearly unchanged for the week, as investors awaited further merger filings with Hecate Energy Group. The SPAC’s stock moved up just 0.2% since May 22, lagging the Nasdaq-100’s 2.9% gain. EGH and Hecate plan to complete their $1.2 billion merger by mid-2026, pending shareholder approval. EGH reported $1.03 million in net income last quarter, mainly from trust interest.
May 30, 2026
POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not
····

POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

Andretti Acquisition Corp. II’s Class A shares (POLE) closed at $10.71 on Thursday, down 0.3% with just 3,504 shares traded. The company, a SPAC, faces a Sept. 9 deadline to complete a business combination or risk liquidation, with filings citing “substantial doubt” about its ability to continue. Its planned merger with StoreDot was terminated in February. Andretti reported $246.4 million in its trust account as of March 31.
May 28, 2026
Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June
····

Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June

Relay Therapeutics shares traded at $14.50 Thursday, holding above last week’s $12 public offering price after raising $296.8 million from a stock sale. The company reported early Phase 2 data showing 60% of evaluable patients with PIK3CA-driven vascular anomalies responded to its drug zovegalisib. Management will present at two major healthcare conferences in June. Relay ended Q1 with $642.1 million in cash.
May 28, 2026
Satellogic stock pops on $18 million injection, 10 million-share filing appears
····

Satellogic stock pops on $18 million injection, 10 million-share filing appears

Satellogic Inc. rose 1.6% to $9.93 Thursday after announcing an $18 million, one-year defense contract and a major shareholder’s plan to sell 10 million shares. The stock traded between $9.47 and $10.11, with market cap near $1.40 billion. First-quarter revenue climbed 80% to $6.1 million, and the company reported positive operating cash flow. Liberty Strategic Capital filed notice to sell shares worth $97.7 million.
May 28, 2026
Radware Drops 3% After Shareholder Vote
····

Radware Drops 3% After Shareholder Vote

Radware shareholders approved all three proposals at the May 25 annual meeting, the company said Wednesday. Shares closed down 3% at $29.00, below the 52-week high. First-quarter revenue rose 11% to $79.8 million, with cloud annual recurring revenue up 23%. Americas revenue climbed 40%, while EMEA fell 11%.
May 28, 2026
Imunon Shares Trade Early After CEO Gets Stock Grant
····

Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon shares rose 3.5% to $2.38 in thin pre-market trading Thursday after an SEC filing showed CEO Stacy Lindborg received 1,491 shares instead of part of her cash salary. The company has warned of “substantial doubt” about its ability to continue operating. Only 531 shares changed hands pre-market. Imunon’s main drug, IMNN-001, remains in Phase 3 trials for advanced ovarian cancer.
May 28, 2026
Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today
····

Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today

Atlas Lithium shares held near $4.15 in early U.S. trading ahead of its annual shareholder meeting at 10:00 a.m. ET. Investors are focused on progress at the Neves lithium project in Brazil, where plant assembly contractor Alfa Engenharia was hired this month. The company expects Neves to produce 146,000 tonnes of lithium concentrate annually. One Series A preferred share holds 51% of voting power at the meeting.
May 28, 2026
Goldman issues warning on CooperCompanies ahead of earnings
····

Goldman issues warning on CooperCompanies ahead of earnings

CooperCompanies shares rose 0.4% to $62.28 after Goldman Sachs cut its price target to $61 and reiterated a Sell rating. The company’s fiscal Q2 results are due June 4. Cooper posted Q1 revenue of $1.024 billion, up 6%, and set a 2026 adjusted EPS outlook of $4.58 to $4.66. $1.5 billion remains on its 2021 term loan, with a recent U.K. tax ruling noted in its latest 10-Q.
May 27, 2026
1 2 3 … 9